Immunosuppressive monocytes (CD14+/HLA-DRlow/−) increase in childhood precursor B-cell acute lymphoblastic leukemia after induction chemotherapy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Medical Oncology

• Publication date

  2018-02-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-018-1092-9PMID 29429058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expansion and activation of granulocytic, myeloid‐derived suppressor cells in childhood precursor B cell acute lymphoblastic leukemia

  2017cited by this paper
• Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.

  2017cited by this paper
• The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

  2016cited by this paper
• Immune independent crosstalk between lymphoma and myeloid suppressor CD14+HLA-DRlow/neg monocytes mediates chemotherapy resistance

  2015cited by this paper
• Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

  2015cited by this paper
• Acute Lymphoblastic Leukemia in Children.

  2015cited by this paper
• Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies

  2014cited by this paper
• Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis.

  2014cited by this paper
• Acute Lymphoblastic Leukemia in Children

  2013cited by this paper
• Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

  2013cited by this paper
• Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

  2012cited by this paper
• Association of an increased frequency of CD14+HLA‐DRlo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL)

  2012cited by this paper
• Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.

  2011cited by this paper
• Immunosuppressive CD14+HLA‐DRlow/− monocytes in prostate cancer

  2010cited by this paper
• A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

  2008cited by this paper
• Combined method for simultaneous morphology, immunophenotype and karyotype (MAC) in leukemias.

  1997cited by this paper

• “Monocytes in B-Cell Malignancies: Their Role in Disease Progression and Therapy Resistance”

  2025cites this paper
• HLA molecules: Another challenge for CAR T cell therapy.

  2025cites this paper
• Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics

  2024cites this paper
• The Promise of Single-cell Technology in Providing New Insights Into the Molecular Heterogeneity and Management of Acute Lymphoblastic Leukemia

  2022cites this paper
• Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood – Interim Analysis of the IMMO-LDRT01 Trial

  2021cites this paper
• Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia

  2021cites this paper
• The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance

  2021cites this paper
• Role of innate immunity in chemotherapy-induced peripheral neuropathy.

  2021cites this paper
• Risk-associated alterations in marrow T cells in pediatric leukemia

  2020cites this paper
• Normal Absolute Monocyte Count at the Time of Relapse is Associated with Improved Survival After First Salvage Therapy in Adult Patients with Early Relapsed B-Lineage Acute Lymphoblastic Leukemia

  2020influential citation